Accordingly, cancer cells-TIM-3+ and sTILs-TIM-3+ are associated with more aggressive clinicopathological features, while total and intra-tumoral TILs expressing TIM-3+ are associated with a more benign behavior. This evidence concerns the gene HAVCR2 and cancer.